Pharmaceutical manufacturers today rely on data in everything from accelerating drug development and improving the efficacy of clinical trials to reducing safety concerns and identifying patient populations.

But the sheer amount of data can be overwhelming. Too often it’s hard to figure out where to get started in the data analytics part. What do you want to know from the data? What are the right questions to ask of the data? And is this even the right data to use?

Jack Timko, a principal with Valuate Health who leads their data analytics team, joins The IDI to help make sense of data and data analytics in pharma and market access.

Connect with Jack Timko on LinkedIn

Learn more about Valuate Health